All In MedTech

Device Trial Radar · NCT01248572

Evaluation of Effective Lens Position With a Uniplanar Bi-aspheric IOL

Evaluation of Lens Effective Position, Stability and Prediction With a 12mm Uniplanar, Biaspheric Intraocular Lens

Last checked: Nov 20, 2026Latest source record: Mar 18, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

40

Actual

Start

Oct 2010

Primary completion

Mar 2012

Study completion Mar 2012

Sponsor

Lead sponsor
Lenstec IncorporatedNot on our public-company list
Sponsor type
Industry
First posted
Nov 25, 2010

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Basic science
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary goal of this study is to determine the effective lens position (ELP) - or location an intraocular lens (IOL) "sits" in the eye - of the Softec HD IOL. A secondary study goal is to determine if measures of the eye taken prior to surgery can reliably predict postoperative ELP.

Conditions

  • Cataract

Interventions

  • Softec HD IOLDevice

    Posterior chamber intraocular lens intended for the replacement of the human crystalline lens following phacoemulsification cataract removal in adults over the age of 21.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Effective Lens PositionTime frame: 6 Months Postoperative

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Barnet-Dulaney-Perkins Eye Center

    Phoenix, Arizona

  • Eye Centers of Florida

    Fort Myers, Florida

  • Harbin Clinic

    Rome, Georgia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.